References
- Martin, P.J., Schoch, G., Fisher, L., Byers, V., Anasetti, C., Appelbaum, F.R., Beatty, P.C., Doney, K., McDonald, G.B. and Sanders, J.E. (1990) “A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment”, Blood 76, 1464–1472.
- Reynaert, H., De Coninck, A., Neven, A.M., Van Camp, B. and Schots, R. (1992) “Chemotherapy-induced aerai erythema and acute graft-versus-host disease after allogeneic bone marrow transplantation”, Bone Marroin Transplant. 10, 185–187.
- Kitamura, K., Aihara, M., Osawa, J., Naito, S. and Ikezawa, Z. (1988) “Clinicohistological study of drug eruptions induced by sulfhydryl drugs”, Proc. Jpn. Soc. Investig. Dermatol. 12, 136–137.
- Chao, N.J., Schmidt, G.M., Niland, J.C., Amylon, M.D., Dagis, A.C., Long, G.W., Nademanee, A.P., Negrin, R.S., O'Donnell, M.R., Parker, P.M., Smith, E.P, Synder, D.S., Stein, A.S., Wong, R.M., Blume, K.G. and Forman, S.J. (1993) “Cyclosporin, methotrexate and prednisone compared with cyclosporin and prednisone for prophylaxis of acute graft-versus-host disease”, N. Engl. J. Med. 329, 1225–1230.
- Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J. and Thomas, E.D. (1995) “1994 Consensus conference on acute GVHD grading”, Bone Marrow Transplant. 15, 825–828.
- Pauly, J.L., Russell, C.W., Planinsek, J.A. and Minowada, J. (1982) “Studies of cultured human T lymphocytes. I. Production of the T cell growth-promoting lymphokine interleukin-2”, J. Immunol. Methods 50, 173–186.
- Foley, R., Couban, S., Walker, I., Greene, K, Chen, C.S., Messner, H. and Gauldie, J. (1998) “Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogeneic bone marrow transplantation”, Bone Marrow Transplant. 21, 769–773.
- Grimm, J., Zeller, W. and Zander, A.R. (1998) “Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantations as a marker for C.VHD”, Bone Marrow Transplant. 21, 29–32.